SEAMLESS PHASE II/III CLINICAL TRIALS WITH COVARIATE ADAPTIVE RANDOMIZATION
From MaRDI portal
Publication:5066789
DOI10.5705/ss.202019.0354MaRDI QIDQ5066789
Wei Ma, Mengxi Wang, Hongjian Zhu
Publication date: 30 March 2022
Published in: Statistica Sinica (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.5705/ss.202019.0354
62-XX: Statistics
Related Items
Cites Work
- A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection
- Adaptive Group Sequential Designs for Clinical Trials: Combining the Advantages of Adaptive and of Classical Group Sequential Approaches
- Seamlessly Expanding a Randomized Phase II Trial to Phase III
- Inference Under Covariate-Adaptive Randomization
- The covariate-adaptive biased coin design for balancing clinical trials in the presence of prognostic factors
- A Multiple Comparison Procedure for Comparing Several Treatments with a Control
- A theory for testing hypotheses under covariate-adaptive randomization
- Two-stage selection and testing designs for comparative clinical trials
- On closed testing procedures with special reference to ordered analysis of variance
- The Simes Method for Multiple Hypothesis Testing With Positively Dependent Test Statistics
- A Unified Theory of Two-Stage Adaptive Designs
- Sequential Monitoring of Covariate-Adaptive Randomized Clinical Trials
- Adaptive Sample Size Calculations in Group Sequential Trials
- An improved Bonferroni procedure for multiple tests of significance
- Evaluation of Experiments with Adaptive Interim Analyses
- Probabilistic Foundation of Confirmatory Adaptive Designs
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts
- Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations
- Inference under covariate‐adaptive randomization with multiple treatments
- Testing Hypotheses of Covariate-Adaptive Randomized Clinical Trials
- Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop‐the‐losers trials
